Longer-Term Safety of B-Cell Therapy With Ocrelizumab in Multiple Sclerosis. Yeh EA, Bourdette D, Wiendl H. Neurology 2021 Sep 2. pii: WNL.0000000000012716.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yeh EA, Bourdette D, Wiendl H. Longer-Term Safety of B-Cell Therapy With Ocrelizumab in Multiple Sclerosis. Neurology 2021 Sep 2. pii: WNL.0000000000012716.
PMID: 34475129